| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.4 | 0.03 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.28 | 0.03 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.15 | 0.03 |